A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis
- PMID: 19193627
- PMCID: PMC2664150
- DOI: 10.1093/hmg/ddp059
A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis
Abstract
The cause of sporadic amyotrophic lateral sclerosis (ALS) is largely unknown, but genetic factors are thought to play a significant role in determining susceptibility to motor neuron degeneration. To identify genetic variants altering risk of ALS, we undertook a two-stage genome-wide association study (GWAS): we followed our initial GWAS of 545 066 SNPs in 553 individuals with ALS and 2338 controls by testing the 7600 most associated SNPs from the first stage in three independent cohorts consisting of 2160 cases and 3008 controls. None of the SNPs selected for replication exceeded the Bonferroni threshold for significance. The two most significantly associated SNPs, rs2708909 and rs2708851 [odds ratio (OR) = 1.17 and 1.18, and P-values = 6.98 x 10(-7) and 1.16 x 10(-6)], were located on chromosome 7p13.3 within a 175 kb linkage disequilibrium block containing the SUNC1, HUS1 and C7orf57 genes. These associations did not achieve genome-wide significance in the original cohort and failed to replicate in an additional independent cohort of 989 US cases and 327 controls (OR = 1.18 and 1.19, P-values = 0.08 and 0.06, respectively). Thus, we chose to cautiously interpret our data as hypothesis-generating requiring additional confirmation, especially as all previously reported loci for ALS have failed to replicate successfully. Indeed, the three loci (FGGY, ITPR2 and DPP6) identified in previous GWAS of sporadic ALS were not significantly associated with disease in our study. Our findings suggest that ALS is more genetically and clinically heterogeneous than previously recognized. Genotype data from our study have been made available online to facilitate such future endeavors.
Figures



Similar articles
-
Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study.Lancet Neurol. 2010 Oct;9(10):986-94. doi: 10.1016/S1474-4422(10)70197-6. Lancet Neurol. 2010. PMID: 20801717 Free PMC article.
-
Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALS.PLoS One. 2012;7(4):e35333. doi: 10.1371/journal.pone.0035333. Epub 2012 Apr 11. PLoS One. 2012. PMID: 22509407 Free PMC article.
-
ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study.Lancet Neurol. 2007 Oct;6(10):869-77. doi: 10.1016/S1474-4422(07)70222-3. Lancet Neurol. 2007. PMID: 17827064
-
[Personal genome analysis in amyotrophic lateral sclerosis].Brain Nerve. 2013 Mar;65(3):257-65. Brain Nerve. 2013. PMID: 23475517 Review. Japanese.
-
Copy Number Variations in Amyotrophic Lateral Sclerosis: Piecing the Mosaic Tiles Together through a Systems Biology Approach.Mol Neurobiol. 2018 Feb;55(2):1299-1322. doi: 10.1007/s12035-017-0393-x. Epub 2017 Jan 24. Mol Neurobiol. 2018. PMID: 28120152 Free PMC article. Review.
Cited by
-
Genetic ablation of IP3 receptor 2 increases cytokines and decreases survival of SOD1G93A mice.Hum Mol Genet. 2016 Aug 15;25(16):3491-3499. doi: 10.1093/hmg/ddw190. Epub 2016 Jul 4. Hum Mol Genet. 2016. PMID: 27378687 Free PMC article.
-
ALS and FTD: an epigenetic perspective.Acta Neuropathol. 2016 Oct;132(4):487-502. doi: 10.1007/s00401-016-1587-4. Epub 2016 Jun 9. Acta Neuropathol. 2016. PMID: 27282474 Free PMC article. Review.
-
Variants within the SP110 nuclear body protein modify risk of canine degenerative myelopathy.Proc Natl Acad Sci U S A. 2016 May 31;113(22):E3091-100. doi: 10.1073/pnas.1600084113. Epub 2016 May 16. Proc Natl Acad Sci U S A. 2016. PMID: 27185954 Free PMC article.
-
Exome sequencing of case-unaffected-parents trios reveals recessive and de novo genetic variants in sporadic ALS.Sci Rep. 2015 Mar 16;5:9124. doi: 10.1038/srep09124. Sci Rep. 2015. PMID: 25773295 Free PMC article.
-
Amyotrophic lateral sclerosis: pathophysiology, diagnosis and management.CNS Drugs. 2011 Jan;25(1):1-15. doi: 10.2165/11586000-000000000-00000. CNS Drugs. 2011. PMID: 21128691 Review.
References
-
- Chiò A., Traynor B.J., Lombardo F., Fimognari M., Calvo A., Ghiglione P., Mutani R., Restagno G. Prevalence of SOD1 mutations in the Italian ALS population. Neurology. 2008;70:533–537. - PubMed
-
- Valdmanis P.N., Rouleau G.A. Genetics of familial amyotrophic lateral sclerosis. Neurology. 2008;70:144–152. - PubMed
-
- Majoor-Krakauer D., Ottman R., Johnson W.G., Rowland L.P. Familial aggregation of amyotrophic lateral sclerosis, dementia, and Parkinson's disease: evidence of shared genetic susceptibility. Neurology. 1994;44:1872–1877. - PubMed
-
- Dunckley T., Huentelman M.J., Craig D.W., Pearson J.V., Szelinger S., Joshipura K., Halperin R.F., Stamper C., Jensen K.R., Letizia D., et al. Whole-genome analysis of sporadic amyotrophic lateral sclerosis. N. Engl. J. Med. 2007;357:775–788. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous